Cartesian Therapeutics
RNAC
#8958
Rank
HK$1.46 B
Marketcap
HK$48.13
Share price
4.24%
Change (1 day)
-14.58%
Change (1 year)

EPS for Cartesian Therapeutics (RNAC)

EPS in 2026 (TTM): -HK$14.49

According to Cartesian Therapeutics's latest financial reports the company's current EPS (TTM) is -HK$14.58. In 2021 the company made an earnings per share (EPS) of -HK$56.44 an increase over its 2020 EPS that were of -HK$162.26.

EPS history for Cartesian Therapeutics from 2016 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-HK$14.49
2021-HK$56.44-65.22%
2020-HK$162.26-43.44%
2019-HK$286.89-58.08%
2018-HK$684.31-9.35%
2017-HK$754.86-29.16%
2016-HK$1,066